Nirogacestat is a targeted tumor treatment for desmoid type fibrosarcoma. SpringWorks Therapeutics reportedly plans to submit a New Drug Application (NDA) to the FDA for review in the upcoming near future. In the below video link, Bernd Kasper, MD, PhD,…